Get started
ALX Oncology Holdings Inc.ALX Oncology Holdings Inc.ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

ALXO chart


Full chart

ALXO upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪29.36 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.6051 USD
Net income (FY)
‪−134.85 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪33.99 M‬
Beta (1Y)
1.36

Employees


Employees (FY)
80
Change (1Y)
+8 +11.11%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.69 M‬ USD

About ALX Oncology Holdings Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Jason Lettmann
Website
alxoncology.com
Headquarters
South San Francisco
Founded
2015
FIGI
BBG00VR8SDG8
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ALXO news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Sparks


Curated watchlists where ALXO is featured.

See all sparks 


Check out other big names from the same industry as ALXO.

Frequently Asked Questions


The current price of ALXO is 0.5500 USD — it has decreased by −1.79% in the past 24 hours. Watch ALX Oncology Holdings Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ALX Oncology Holdings Inc. stocks are traded under the ticker ALXO.
ALXO stock has risen by 7.84% compared to the previous week, the month change is a −30.20% fall, over the last year ALX Oncology Holdings Inc. has showed a −96.23% decrease.
We've gathered analysts' opinions on ALX Oncology Holdings Inc. future price: according to them, ALXO price has a max estimate of 9.00 USD and a min estimate of 2.20 USD. Watch ALXO chart and read a more detailed ALX Oncology Holdings Inc. stock forecast: see what analysts think of ALX Oncology Holdings Inc. and suggest that you do with its stocks.
ALXO reached its all-time high on Dec 10, 2020 with the price of 117.4500 USD, and its all-time low was 0.4600 USD and was reached on Apr 10, 2025. View more price dynamics on ALXO chart.
See other stocks reaching their highest and lowest prices.
ALXO stock is 6.62% volatile and has beta coefficient of 1.36. Track ALX Oncology Holdings Inc. stock price on the chart and check out the list of the most volatile stocks — is ALX Oncology Holdings Inc. there?
Today ALX Oncology Holdings Inc. has the market capitalization of ‪29.36 M‬, it has increased by 5.11% over the last week.
Yes, you can track ALX Oncology Holdings Inc. financials in yearly and quarterly reports right on TradingView.
ALX Oncology Holdings Inc. is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
ALXO earnings for the last quarter are −0.55 USD per share, whereas the estimation was −0.67 USD resulting in a 17.91% surprise. The estimated earnings for the next quarter are −0.47 USD per share. See more details about ALX Oncology Holdings Inc. earnings.
ALX Oncology Holdings Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ALXO net income for the last quarter is ‪−29.16 M‬ USD, while the quarter before that showed ‪−30.71 M‬ USD of net income which accounts for 5.03% change. Track more ALX Oncology Holdings Inc. financial stats to get the full picture.
No, ALXO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 21, 2025, the company has 80 employees. See our rating of the largest employees — is ALX Oncology Holdings Inc. on this list?
Like other stocks, ALXO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALX Oncology Holdings Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALX Oncology Holdings Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALX Oncology Holdings Inc. stock shows the sell signal. See more of ALX Oncology Holdings Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.